This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
And I have gone through my not-so-long career, but it’s coming up on nine years now, seeing the way that we have talked about CPR in such problematic ways, in ways that really do not enable true informedconsent. So I think consenting to a course of treatment involves that two-way conversation. Sunita: Oh, yeah.
I think the two spaces it comes out of, one is informedconsent, which is this idea that people need to have an understanding of their disease and treatment. But I think it’s artificial, as we’ve already shown in this conversation, to talk about that as a isolated event. Gretchen: Absolutely.
Psilocybin, the most commonly used psychedelic, increases heart rate and blood pressure, which may potentially lead to cardiovascular events. But patients have reported that they still recounted that event as something that was quite transformative and beneficial for them as well. Most participants are White and well-resourced.
And so Ruth highlighted one of the features of this pragmatic trial that was different than the outpatient trial was that we didn’t need to consent patients and families for participation in this study. And so that’s how we were able to proceed with the study under this waiver of consent.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content